News – Page 188 – Endpoints News

After years of delay, BeiGene finally lands FDA approval for its PD-1 drug

Last year

FDA adcomm votes in favor of Geron's anemia drug for cancer patients despite questions on risk

Last year

FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease

Last year

European Parliament to dig into pharma legislative revision next week

Last year

Pharma mass-market TV advertising fading in favor of personalized media, agency says

Last year

Lawmakers amp up calls for PBM reforms to be included in next week's funding package

Last year

UK's NICE says it's not ready to recommend Vertex's Casgevy for sickle cell

Last year

BeiGene looks beyond China as it secures new API source, nears opening of US site

Last year

An API producer’s $250M expansion; Noramco launches US API supply; A packaging company’s 47% sales jump

Last year

Coherus' new focus on oncology leads to restructuring, 30% layoffs

Last year

Female investors track progress, call for more women on boards and in leadership roles

Last year

OcuTerra’s diabetic retinopathy drug fails PhII; Better Therapeutics to shut down

Last year

Pfizer-backed UK biotech raises £25M to advance mitophagy pipeline

Last year

The Change Healthcare hack could be a catalyst for real healthcare cybersecurity improvement

Last year

German ADC biotech Tubulis raises $138M to enter the clinic and expand in US

Last year

Spruce Biosciences’ stock plummets in wake of PhIIb flop, biotech to cut staff

Last year

AstraZeneca eyes rare endocrinology market with $1.05B buyout of Amolyt Pharma

Last year

Swedish biotech raises €30M Series A to develop off-the-shelf gene therapy for solid tumors

Last year

Mirum expands label for rare liver disease drug, serving up more competition for Ipsen's Bylvay

Last year

BIO to cut ties with WuXi after trade group was accused of acting as a foreign agent

Last year

FDA raises concerns of 'early deaths' in Abecma and Carvykti multiple myeloma trials

Last year

Alnylam takes a family road trip to talk about health history and heredity in new rare disease campaign

Last year

Federal appeals court rules in favor of Arkansas in PhRMA's suit over 340B expansion

Last year

Pharma industry reputation remains steady at a ‘new normal’ after Covid, Harris Poll finds

Last year

First page Previous page 185 186 187188189 190 191 Next page Last page